Table 4

Construct validity of different modifications of the mSCQ and the RDCI with health outcomes in all patients, and subgroups of patients with axSpA and pSpA

AgeBASFIEQ-5Dpatient's global assessment of well-beingWPAI, impact on work productivityaImpact on daily activitiesASDAS- CRP
All patients (n = 3984)
    mSCQ0.410.34−0.330.220.210.300.19
    mSCQ + EAMs0.450.32−0.330.19c0.16c0.26c0.16c
    mSCQ + fractures0.400.34−0.330.210.200.290.19
    mSCQ + osteoporosis + fracture0.410.34−0.330.220.210.300.19
    mSCQ + EAMs + osteoporosis0.46c0.32−0.330.200.17c0.270.16c
    mSCQ + EAMs + fractures0.450.32−0.330.19c0.17c0.270.16c
    mSCQ + EAMs + osteoporosis + fractures0.450.33−0.330.200.17c0.270.17
    RDCIb0.47c0.24c−0.21c0.12c0.09c0.17c0.10c
Patients fulfilling ASAS axSpA criteria (n = 2955)
    mSCQ0.380.35d−0.35d0.21d0.20d0.29d0.19d
    mSCQ + EAMs0.42c0.34−0.34d0.20d0.17c,d0.270.17c,d
    mSCQ + fractures0.380.35d−0.34d0.21d0.20d0.30d0.18d
    mSCQ + osteoporosis + fracture0.390.35d−0.340.22d0.20d0.30d0.19d
    mSCQ + EAMs + osteoporosis0.42c0.34−0.34d0.20d0.17c,d0.280.18d
    mSCQ + EAMs + fractures0.42c0.34−0.34d0.20d0.17c,d0.270.17c,d
    mSCQ + EAMs + osteoporosis + fractures0.42c0.34−0.34d0.20d0.17c,d0.280.17c,d
    RDCIb0.44c0.25c,d−0.22c0.12c,d0.08c,d0.17c,d0.10c,d
Patients fulfilling ASAS pSpA criteria (n = 415)
    mSCQ0.400.46d−0.29d0.19d0.29d0.32d0.25d
    mSCQ + EAMs0.45c0.35c−0.29d0.15c,d0.22c,d0.27c0.19c,d
    mSCQ + fractures0.400.41c,d−0.30d0.18d0.30d0.33d0.26d
    mSCQ + osteoporosis + fracture0.400.42d−0.310.19d0.32c,d0.34d0.26d
    mSCQ + EAMs + osteoporosis0.45c0.36c−0.27d0.16c,d0.24c,d0.280.19c
    mSCQ + EAMs + fractures0.45c0.37c−0.26c,d0.15c,d0.24c,d0.27c0.19c,d
    mSCQ + EAMs + osteoporosis + fractures0.46c0.37c−0.27d0.15c,d0.26c,d0.290.20c,d
    RDCIb0.420.35c,d−0.23c0.16c,d0.25c,d0.24c,d0.22c,d
AgeBASFIEQ-5Dpatient's global assessment of well-beingWPAI, impact on work productivityaImpact on daily activitiesASDAS- CRP
All patients (n = 3984)
    mSCQ0.410.34−0.330.220.210.300.19
    mSCQ + EAMs0.450.32−0.330.19c0.16c0.26c0.16c
    mSCQ + fractures0.400.34−0.330.210.200.290.19
    mSCQ + osteoporosis + fracture0.410.34−0.330.220.210.300.19
    mSCQ + EAMs + osteoporosis0.46c0.32−0.330.200.17c0.270.16c
    mSCQ + EAMs + fractures0.450.32−0.330.19c0.17c0.270.16c
    mSCQ + EAMs + osteoporosis + fractures0.450.33−0.330.200.17c0.270.17
    RDCIb0.47c0.24c−0.21c0.12c0.09c0.17c0.10c
Patients fulfilling ASAS axSpA criteria (n = 2955)
    mSCQ0.380.35d−0.35d0.21d0.20d0.29d0.19d
    mSCQ + EAMs0.42c0.34−0.34d0.20d0.17c,d0.270.17c,d
    mSCQ + fractures0.380.35d−0.34d0.21d0.20d0.30d0.18d
    mSCQ + osteoporosis + fracture0.390.35d−0.340.22d0.20d0.30d0.19d
    mSCQ + EAMs + osteoporosis0.42c0.34−0.34d0.20d0.17c,d0.280.18d
    mSCQ + EAMs + fractures0.42c0.34−0.34d0.20d0.17c,d0.270.17c,d
    mSCQ + EAMs + osteoporosis + fractures0.42c0.34−0.34d0.20d0.17c,d0.280.17c,d
    RDCIb0.44c0.25c,d−0.22c0.12c,d0.08c,d0.17c,d0.10c,d
Patients fulfilling ASAS pSpA criteria (n = 415)
    mSCQ0.400.46d−0.29d0.19d0.29d0.32d0.25d
    mSCQ + EAMs0.45c0.35c−0.29d0.15c,d0.22c,d0.27c0.19c,d
    mSCQ + fractures0.400.41c,d−0.30d0.18d0.30d0.33d0.26d
    mSCQ + osteoporosis + fracture0.400.42d−0.310.19d0.32c,d0.34d0.26d
    mSCQ + EAMs + osteoporosis0.45c0.36c−0.27d0.16c,d0.24c,d0.280.19c
    mSCQ + EAMs + fractures0.45c0.37c−0.26c,d0.15c,d0.24c,d0.27c0.19c,d
    mSCQ + EAMs + osteoporosis + fractures0.46c0.37c−0.27d0.15c,d0.26c,d0.290.20c,d
    RDCIb0.420.35c,d−0.23c0.16c,d0.25c,d0.24c,d0.22c,d
a

Work productivity in those currently employed.

b

The RDCI was calculated according to the information from the physician, except for depression which was retrieved from the patient.

c

Difference of comorbidity score with mSCQ score >10%.

d

Difference on correlation between axSpA and pSpA >10%. EAM: extra-articular manifestations; EQ-5D: Euroqol 5 D; mSCQ: modified self-administered comorbidity index; RDCI: rheumatic disease comorbidity index; WPAI: work productivity and activity impairment.

Table 4

Construct validity of different modifications of the mSCQ and the RDCI with health outcomes in all patients, and subgroups of patients with axSpA and pSpA

AgeBASFIEQ-5Dpatient's global assessment of well-beingWPAI, impact on work productivityaImpact on daily activitiesASDAS- CRP
All patients (n = 3984)
    mSCQ0.410.34−0.330.220.210.300.19
    mSCQ + EAMs0.450.32−0.330.19c0.16c0.26c0.16c
    mSCQ + fractures0.400.34−0.330.210.200.290.19
    mSCQ + osteoporosis + fracture0.410.34−0.330.220.210.300.19
    mSCQ + EAMs + osteoporosis0.46c0.32−0.330.200.17c0.270.16c
    mSCQ + EAMs + fractures0.450.32−0.330.19c0.17c0.270.16c
    mSCQ + EAMs + osteoporosis + fractures0.450.33−0.330.200.17c0.270.17
    RDCIb0.47c0.24c−0.21c0.12c0.09c0.17c0.10c
Patients fulfilling ASAS axSpA criteria (n = 2955)
    mSCQ0.380.35d−0.35d0.21d0.20d0.29d0.19d
    mSCQ + EAMs0.42c0.34−0.34d0.20d0.17c,d0.270.17c,d
    mSCQ + fractures0.380.35d−0.34d0.21d0.20d0.30d0.18d
    mSCQ + osteoporosis + fracture0.390.35d−0.340.22d0.20d0.30d0.19d
    mSCQ + EAMs + osteoporosis0.42c0.34−0.34d0.20d0.17c,d0.280.18d
    mSCQ + EAMs + fractures0.42c0.34−0.34d0.20d0.17c,d0.270.17c,d
    mSCQ + EAMs + osteoporosis + fractures0.42c0.34−0.34d0.20d0.17c,d0.280.17c,d
    RDCIb0.44c0.25c,d−0.22c0.12c,d0.08c,d0.17c,d0.10c,d
Patients fulfilling ASAS pSpA criteria (n = 415)
    mSCQ0.400.46d−0.29d0.19d0.29d0.32d0.25d
    mSCQ + EAMs0.45c0.35c−0.29d0.15c,d0.22c,d0.27c0.19c,d
    mSCQ + fractures0.400.41c,d−0.30d0.18d0.30d0.33d0.26d
    mSCQ + osteoporosis + fracture0.400.42d−0.310.19d0.32c,d0.34d0.26d
    mSCQ + EAMs + osteoporosis0.45c0.36c−0.27d0.16c,d0.24c,d0.280.19c
    mSCQ + EAMs + fractures0.45c0.37c−0.26c,d0.15c,d0.24c,d0.27c0.19c,d
    mSCQ + EAMs + osteoporosis + fractures0.46c0.37c−0.27d0.15c,d0.26c,d0.290.20c,d
    RDCIb0.420.35c,d−0.23c0.16c,d0.25c,d0.24c,d0.22c,d
AgeBASFIEQ-5Dpatient's global assessment of well-beingWPAI, impact on work productivityaImpact on daily activitiesASDAS- CRP
All patients (n = 3984)
    mSCQ0.410.34−0.330.220.210.300.19
    mSCQ + EAMs0.450.32−0.330.19c0.16c0.26c0.16c
    mSCQ + fractures0.400.34−0.330.210.200.290.19
    mSCQ + osteoporosis + fracture0.410.34−0.330.220.210.300.19
    mSCQ + EAMs + osteoporosis0.46c0.32−0.330.200.17c0.270.16c
    mSCQ + EAMs + fractures0.450.32−0.330.19c0.17c0.270.16c
    mSCQ + EAMs + osteoporosis + fractures0.450.33−0.330.200.17c0.270.17
    RDCIb0.47c0.24c−0.21c0.12c0.09c0.17c0.10c
Patients fulfilling ASAS axSpA criteria (n = 2955)
    mSCQ0.380.35d−0.35d0.21d0.20d0.29d0.19d
    mSCQ + EAMs0.42c0.34−0.34d0.20d0.17c,d0.270.17c,d
    mSCQ + fractures0.380.35d−0.34d0.21d0.20d0.30d0.18d
    mSCQ + osteoporosis + fracture0.390.35d−0.340.22d0.20d0.30d0.19d
    mSCQ + EAMs + osteoporosis0.42c0.34−0.34d0.20d0.17c,d0.280.18d
    mSCQ + EAMs + fractures0.42c0.34−0.34d0.20d0.17c,d0.270.17c,d
    mSCQ + EAMs + osteoporosis + fractures0.42c0.34−0.34d0.20d0.17c,d0.280.17c,d
    RDCIb0.44c0.25c,d−0.22c0.12c,d0.08c,d0.17c,d0.10c,d
Patients fulfilling ASAS pSpA criteria (n = 415)
    mSCQ0.400.46d−0.29d0.19d0.29d0.32d0.25d
    mSCQ + EAMs0.45c0.35c−0.29d0.15c,d0.22c,d0.27c0.19c,d
    mSCQ + fractures0.400.41c,d−0.30d0.18d0.30d0.33d0.26d
    mSCQ + osteoporosis + fracture0.400.42d−0.310.19d0.32c,d0.34d0.26d
    mSCQ + EAMs + osteoporosis0.45c0.36c−0.27d0.16c,d0.24c,d0.280.19c
    mSCQ + EAMs + fractures0.45c0.37c−0.26c,d0.15c,d0.24c,d0.27c0.19c,d
    mSCQ + EAMs + osteoporosis + fractures0.46c0.37c−0.27d0.15c,d0.26c,d0.290.20c,d
    RDCIb0.420.35c,d−0.23c0.16c,d0.25c,d0.24c,d0.22c,d
a

Work productivity in those currently employed.

b

The RDCI was calculated according to the information from the physician, except for depression which was retrieved from the patient.

c

Difference of comorbidity score with mSCQ score >10%.

d

Difference on correlation between axSpA and pSpA >10%. EAM: extra-articular manifestations; EQ-5D: Euroqol 5 D; mSCQ: modified self-administered comorbidity index; RDCI: rheumatic disease comorbidity index; WPAI: work productivity and activity impairment.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close